Cytokinetics eps
WebApr 6, 2024 · EPS-$4.25; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 10.34M 03/15/23 % of Float Shorted 11.58%; Average Volume 992.07K; ... Cytokinetics, Inc. is a biopharmaceutical company ... WebFeb 17, 2024 · This biopharmaceutical company is expected to post quarterly loss of $0.89 per share in its upcoming report, which represents a year-over-year change of -43.6%. Revenues are expected to be $4.84...
Cytokinetics eps
Did you know?
WebCytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of …
WebApr 13, 2024 · During the same quarter in the previous year, the firm posted ($0.36) EPS. Research analysts predict that Cytokinetics, Incorporated will post -4.4 earnings per share for the current fiscal year. Insiders Place Their Bets. In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday ... WebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2024, as a material inducement to their …
WebApr 10, 2024 · The company is expected to report EPS of $2.50, down 6.37% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $23.56 billion, up 0.59% from ... Web18 hours ago · Price & EPS Surprise; 12 Month EPS; Broker Recommendations; Financials ... Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04/03/23-4:00PM EST GlobeNewswire
WebDec 31, 2024 · Analysts estimate that Cytokinetics will report an earnings per share (EPS) of $-1.21. Cytokinetics bulls will hope to hear the company announce they've not only beaten that estimate, but...
WebApr 9, 2024 · As a group, equities analysts anticipate that Cytokinetics, Incorporated will post -4.4 EPS for the current fiscal year. Cytokinetics Company Profile . Cytokinetics, Inc is a biopharmaceutical ... im in libraryWebApr 9, 2024 · Cytokinetics (NASDAQ:CYTK – Get Rating) last issued its quarterly earnings results on Wednesday, March 1st.The biopharmaceutical company reported ($1.45) EPS for the quarter, missing analysts ... iminlikewithyouWebFeb 28, 2024 · February 28, 2024 — 08:40 am EST. Written by Zacks Equity Research for Zacks ->. Investors are always looking for stocks that are poised to beat at earnings season and Cytokinetics, Incorporated ... im inj locationsWebOct 14, 2024 · Cytokinetics is a member of our Medical group, which includes 1189 different companies and currently sits at #3 in the Zacks Sector Rank. ... The consensus estimate for Humana's current year EPS ... iminlikewithyou gamesWebEPS for Cytokinetics (CYTK) EPS in 2024 (TTM): -$4.25. According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -$4.25. In 2024 the company … im injection testosteroneWebFeb 22, 2024 · This biopharmaceutical company is expected to post quarterly loss of $1.22 per share in its upcoming report, which represents a year-over-year change of -238.9%. Revenues are expected to be $7.46... imink lash and brow academyWebA company's earnings per share, or EPS, is a key financial metric on its income statement that investors and analysts use to assess its performance and stock price. EPS is the net … im in lobby